German Inflammatory Bowel Diseases Study Group

Recent papers from German Inflammatory Bowel Diseases Study Group

1. Fully automated determination of metabolic tumor volume in Hodgkin lymphomaEJNMMI Physics · 2026
2. BrECADD in three days: Implementation of a condensed intensive first‐line regimen in Hodgkin lymphomaBritish Journal of Haematology · 2026
3. Prognostic impact of presentation phenotypes in early‐stage favorable Hodgkin lymphomaCancer · 2026
4. Exome sequencing directly implicates 68 genes in inflammatory bowel disease2026
5. Venetoclax combinations in untreated CLL: 5-year results and patient-reported outcome analysis of the CLL13/GAIA trialBlood · 2026
6. Abstract PS4-01-16: The transcriptomic profile of circulating T lymphocytes is associated with response to neoadjuvant therapy in patients with early breast cancerClinical Cancer Research · 2026
7. MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assayBlood · 2026
8. BrECADD vs BEACOPP and Health-Related Quality of Life in Advanced-Stage Hodgkin LymphomaJAMA Oncology · 2026
9. Trends and Characteristics of Corneal Transplantation in South Korea (2021–2023): A Three-Year Analysis of Domestic Survey and Eversight Eye Bank DataOphthalmic Epidemiology · 2026
10. P0750Therapy courses of advanced therapies for Inflammatory Bowel Disease (IBD): results from the TARGET register for patients with IBD in GermanyJournal of Crohn s and Colitis · 2026
11. Association between metabolic tumor burden and health-related quality of life in patients with classic Hodgkin lymphomaEuropean Journal of Nuclear Medicine and Molecular Imaging · 2025
12. Eggerthella lenta Produces a Cryptic Pro-inflammatory LipidJournal of the American Chemical Society · 2025
13. 449 | BRIDGING TO CAR‐T CELL THERAPY IN LARGE B‐CELL LYMPHOMA WITH EITHER CONVENTIONAL THERAPY OR THE CD3xCD20 BISPECIFIC ANTIBODY GLOFITAMABHematological Oncology · 2025
14. IGH rearrangements in Down syndrome acute lymphoblastic leukemiaEJC Paediatric Oncology · 2025
15. T-cell diversity and exclusion of blood-derived T-cells in the tumor microenvironment of classical Hodgkin LymphomaLeukemia · 2024
16. Differential Gene Expression and Transcriptomics Reveal High M‐Gene Expression in JN.1 and KP.1/2 Omicron Sub‐Variants of SARS‐CoV‐2: Implications for Developing More Sensitive Diagnostic TestsJournal of Medical Virology · 2024
17. Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin LymphomaJournal of Clinical Oncology · 2024
18. Differential Gene Expression and Transcriptomics Reveal High M-Gene Expression in JN.1 and KP.1/2 Omicron Sub-Variants of SARS-CoV-2: Implications for Developing More Sensitive Diagnostic Tests2024
19. Assessing the efficacy and tolerability of PET-guided BrECADD versus eBEACOPP in advanced-stage, classical Hodgkin lymphoma (HD21): a randomised, multicentre, parallel, open-label, phase 3 trialThe Lancet · 2024
20. Treatment approaches for older Hodgkin lymphoma patientsCurrent Opinion in Oncology · 2024